Pharma acquisition case study: Lundbeck to acquire Alder BioPharmaceuticals for US$ 1.95 billion
H. Lundbeck A/S (Lundbeck) and Alder BioPharmaceuticals (Alder) announced a definitive agreement for Lundbeck to acquire Alder. About the deal: Under the... Read More
Mitsubishi Tanabe Pharma, Daiichi Sankyo enters licensing agreement for ALS treatment agent edaravone in Brazil
Posted on18 Sep 2019
Comments0
Mitsubishi Tanabe Pharma Corporation and Daiichi Sankyo announced that they have concluded a licensing agreement covering commercialization rights in Brazil for an... Read More
GSK to acquire Celiac-Focused Sitari Pharmaceuticals
GlaxoSmithKline will acquire San Diego-based Sitari Pharmaceuticals and its transglutaminase 2 small molecule program for celiac disease. Sitari, a preclinical-stage biotech, is... Read More
Pharma brand acquisition case study: Amgen to acquire Celgene’s Otezla
Amgen announced today that it has entered into an agreement with Celgene Corporation in connection with its previously announced merger with Bristol-Myers... Read More
Case Study : Rituxan – A Brand which Pharma Industry reckon
Brand Name: Rituxan Company: Roche 2017 U.S. sales: $4.41 billion Disease: Blood cancers, rheumatoid arthritis Dosage form: Injection for Intravenous Use Rituxan (rituximab) is a... Read More
Case Study: Gilead and Galapagos – R&D collaboration
Posted on15 Jul 2019
Comments0
Gilead Sciences, Inc. and Galapagos NV have entered into a 10-year global research and development collaboration. Through this agreement, Gilead will gain... Read More
Gilead introduces Asia Pacific Rainbow Grants program
Gilead Sciences announced the launch of the 2019 Gilead Asia Pacific Rainbow Grants programme to support community-led programs for people living with... Read More
Case Analysis: Insight on AbbVie’s acquisition of Allergan
On June 25, 2019, AbbVie Inc. and Allergan announced that the companies have entered into a definitive transaction agreement under which AbbVie... Read More
Glenmark’s licensing deal with Novartis to distribute three respiratory drugs in Brazil
Glenmark Farmacêutica, has entered into an exclusive partnership agreement with Novartis to distribute latter’s three respiratory products in Brazil. Under the terms... Read More
A triple-combination therapy for COPD – Breztri Aerosphere’s of AstraZeneca received approval in Japan
Posted on21 Jun 2019
Comments0
AstraZeneca announced that Breztri Aerosphere (budesonide/ glycopyrronium/ formoterol fumarate), formerly PT010, has been approved in Japan as a triple-combination therapy to relieve... Read More